124 related articles for article (PubMed ID: 3375779)
1. In vivo production of thromboxane and prostacyclin in patients following total hip arthroplasty.
Vesterqvist O; Schött U; Berséus O; Axelsson K; Gréen K
Scand J Clin Lab Invest; 1988 May; 48(3):233-9. PubMed ID: 3375779
[TBL] [Abstract][Full Text] [Related]
2. Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry.
Chiabrando C; Pinciroli V; Campoleoni A; Benigni A; Piccinelli A; Fanelli R
J Chromatogr; 1989 Oct; 495():1-11. PubMed ID: 2613794
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
[TBL] [Abstract][Full Text] [Related]
4. Synthetic arterial grafts cause prolonged increase in the in vivo formation of thromboxane and prostacyclin in humans.
Vesterqvist O; Gréen K; Lewin J; Swedenborg J
Res Exp Med (Berl); 1987; 187(3):175-84. PubMed ID: 3303204
[TBL] [Abstract][Full Text] [Related]
5. Thromboxane and prostacyclin formation in patients with deep vein thrombosis.
Vesterqvist O; Gréen K; Johnsson H
Thromb Res; 1987 Feb; 45(4):393-402. PubMed ID: 3554598
[TBL] [Abstract][Full Text] [Related]
6. Rapid recovery of in vivo prostacyclin formation after inhibition by aspirin. Evidence from measurements of the major urinary metabolite of prostacyclin by GC-MS.
Vesterqvist O
Eur J Clin Pharmacol; 1986; 30(1):69-73. PubMed ID: 3519239
[TBL] [Abstract][Full Text] [Related]
7. Increased prostacyclin production during exercise in untrained and trained men: effect of low-dose aspirin.
Böger RH; Bode-Böger SM; Schröder EP; Tsikas D; Frölich JC
J Appl Physiol (1985); 1995 May; 78(5):1832-8. PubMed ID: 7649919
[TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
Aitokallio-Tallberg AM; Jung JK; Kim SJ; Viinikka LU; Ylikorkala RO
Cancer Res; 1991 Aug; 51(16):4146-8. PubMed ID: 1868436
[TBL] [Abstract][Full Text] [Related]
9. Prostacyclin and thromboxane in pregnant and nonpregnant women in response to exercise.
Rauramo I; Ilmonen S; Viinikka L; Ylikorkala O
Obstet Gynecol; 1995 Jun; 85(6):1027-30. PubMed ID: 7770249
[TBL] [Abstract][Full Text] [Related]
10. In vivo production of prostacyclin and thromboxane in patients with acute myocardial infarction.
Henriksson P; Wennmalm A; Edhag O; Vesterqvist O; Green K
Br Heart J; 1986 Jun; 55(6):543-8. PubMed ID: 3521690
[TBL] [Abstract][Full Text] [Related]
11. Urinary metabolites of thromboxane and prostacyclin in diabetes mellitus.
Gréen K; Vesterqvist O; Grill V
Acta Endocrinol (Copenh); 1988 Jun; 118(2):301-5. PubMed ID: 3291538
[TBL] [Abstract][Full Text] [Related]
12. Effects of naproxen on the in vivo synthesis of thromboxane and prostacyclin in man.
Vesterqvist O; Gréen K
Eur J Clin Pharmacol; 1989; 37(6):563-5. PubMed ID: 2515064
[TBL] [Abstract][Full Text] [Related]
13. Determination of 6-keto-PGF1 alpha, 2,3-dinor-6-keto-PGF1 alpha, thromboxane B2, 2,3-dinor-thromboxane B2, PGE2, PGD2 and PGF2 alpha in human urine by gas chromatography-negative ion chemical ionization mass spectrometry.
Weber C; Höller M; Beetens J; De Clerck F; Tegtmeier F
J Chromatogr; 1991 Jan; 562(1-2):599-611. PubMed ID: 2026723
[TBL] [Abstract][Full Text] [Related]
14. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
[TBL] [Abstract][Full Text] [Related]
15. Formation of prostacyclin and thromboxane in man as measured by the main urinary metabolites.
Fischer S; Bernutz C; Meier H; Weber PC
Biochim Biophys Acta; 1986 Apr; 876(2):194-9. PubMed ID: 3754157
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretion of prostacyclin and thromboxane metabolites in threatened preterm labor: effect of indomethacin and nylidrin.
Kurki T; Viinikka L; Ylikorkala O
Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):150-4. PubMed ID: 1733190
[TBL] [Abstract][Full Text] [Related]
17. Increased total body synthesis of prostacyclin in rats with adjuvant arthritis.
Stichtenoth DO; Selve N; Tsikas D; Gutzki FM; Frölich JC
Prostaglandins; 1995; 50(5-6):331-40. PubMed ID: 8838242
[TBL] [Abstract][Full Text] [Related]
18. Solid- and liquid-phase extraction for the gas chromatographic-tandem mass spectrometric quantification of 2,3-dinor-thromboxane B2 and 2,3-dinor-6-oxo-prostaglandin F1 alpha in human urine.
Tsikas D; Gutzki FM; Böhme M; Fuchs I; Frölich JC
J Chromatogr A; 2000 Jul; 885(1-2):351-9. PubMed ID: 10941682
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane dominance and prostacyclin deficiency in habitual abortion.
Tulppala M; Viinikka L; Ylikorkala O
Lancet; 1991 Apr; 337(8746):879-81. PubMed ID: 1672969
[TBL] [Abstract][Full Text] [Related]
20. Kidney Transplantation in a Patient Lacking Cytosolic Phospholipase A
Mitchell JA; Knowles RB; Kirkby NS; Reed DM; Edin ML; White WE; Chan MV; Longhurst H; Yaqoob MM; Milne GL; Zeldin DC; Warner TD
Circ Res; 2018 Feb; 122(4):555-559. PubMed ID: 29298774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
